Bristol-Myers Squibb
BMY
BMY
2,245 hedge funds and large institutions have $79.7B invested in Bristol-Myers Squibb in 2024 Q3 according to their latest regulatory filings, with 265 funds opening new positions, 814 increasing their positions, 923 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.6% more ownership
Funds ownership: 75.53% → 76.13% (+0.6%)
6% less call options, than puts
Call options by funds: $1.88B | Put options by funds: $1.99B
12% less repeat investments, than reductions
Existing positions increased: 814 | Existing positions reduced: 923
Holders
2,245
Holding in Top 10
26
Calls
$1.88B
Puts
$1.99B
Top Buyers
| 1 | +$365M | |
| 2 | +$256M | |
| 3 | +$221M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$206M |
| 5 |
Millennium Management
New York
|
+$191M |
Top Sellers
| 1 | -$660M | |
| 2 | -$305M | |
| 3 | -$210M | |
| 4 |
Squarepoint
New York
|
-$203M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$195M |